MedPath

Gastric Emptying After Tea With Milk in Pregnancy.

Not Applicable
Completed
Conditions
Gastric Emptying
Registration Number
NCT03694509
Lead Sponsor
Coombe Women and Infants University Hospital
Brief Summary

The aim of the study is to assess the difference in gastric emptying using ultrasound of pregnant patients following a cup of tea with milk or a similar volume of water.

Detailed Description

The study involves the allocation of either 250ml of water or 200ml of tea and 50ml of milk to fasted parturients, and assessment of gastric antrum CSA at intervals up to 2 hours. The study will be performed in patients with \>34 weeks gestation at the antenatal clinic. The participants will be randomized into one of two groups with an internet based randomisation tool, and then allocated to either group as per the allocation in a sealed opaque envelope. The ultrasound assessor will be blinded to the group allocation.

Participants will be asked to come to clinic in the morning fasting from solids for \>6 hours and for 2 hours for clear fluids. Gastric ultrasound will be performed on the fasted pregnant patients in the right lateral decubitus position to establish a baseline and ensure that the gastric antrum is empty. Gastric antrum CSA will be measured.

Intervention group:

The intervention group will be given 200ml of black breakfast tea with 50ml of full fat milk. This should be consumed within 5 minutes. Gastric ultrasound will be performed at intervals up to 2 hours after the intervention in the right lateral decubitus position. Gastric antrum CSA will be measured. Three measurements of CSA will be taken and averaged.

Placebo group:

The placebo group will be given 250ml of water. This should be consumed within 5 minutes. Gastric ultrasound will be performed at intervals up to 2 hours after the intervention in the right lateral decubitus position. Gastric antrum CSA will be measured. Three measurements of CSA will be taken and averaged.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
50
Inclusion Criteria
  • Women with a singleton pregnancy >36 weeks.
  • Subjects must be female, aged 18 years or above at baseline.
  • Subjects must be able and willing to give written informed consent and to comply with the requirements of this study protocol.
Exclusion Criteria
  • Allergy/sensitivity to milk/tea.
  • A medical or surgical condition leading to delayed gastric emptying (e.g. Diabetes Mellitus).
  • Not fasting for 6 hours for food or 2 hours for clear fluids.
  • No baseline ultrasound assessment.
  • Inability to visualize the gastric antrum.
  • Vomiting or inability to finish drink.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Gastric emptying at 2 hours - supine.120 mins

The difference in gastric antrum cross sectional area (CSA) between groups, measured using ultrasound in a 45° semirecumbent supine position.

Secondary Outcome Measures
NameTimeMethod
Gastric antrum CSA - supine.15 mins, 30 mins, 45 mins, 60 mins, 90 mins

The difference in gastric antrum cross sectional area (CSA) between groups, measured using ultrasound in a 45° semirecumbent supine position.

Gastric antrum CSA - RLD.15 mins, 30 mins, 45 mins, 60 mins, 90 mins, 120 mins

The difference in gastric antrum cross sectional area (CSA) between groups, measured using ultrasound in the 45° semirecumbent RLD (Right lateral decubitus) position.

Gastric volume - RLD.15 mins, 30 mins, 45 mins, 60 mins, 90 mins, 120 mins

The difference in gastric volume as calculated using the determined CSA in the 45° semirecumbent RLD position.

Gastric volume - supine.15 mins, 30 mins, 45 mins, 60 mins, 90 mins, 120 mins

The difference in gastric volume as calculated using the determined CSA in the 45° semirecumbent supine position.

Trial Locations

Locations (1)

Coombe Women and Infants University Hospital

🇮🇪

Dublin, Ireland

Coombe Women and Infants University Hospital
🇮🇪Dublin, Ireland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.